- Record: found
- Abstract: not found
- Article: not found
Efficacité et tolérance du baricitinib dans la dermatite atopique modérée à sévère: résultats de deux études de phase 3 en monothérapie sur 16 semaines, randomisées, en double-aveugle, contrôlées versus placebo (BREEZE-AD1 et BREEZE AD-2)
E.L. Simpson ,
J.P. Lacour ,
L. Spelman ,
R. Galimberti ,
L.F. Eichenfield ,
R. Bissonnette ,
B. King ,
J.P. Thyssen ,
J.I. Silverberg ,
T. Bieber ,
K. Kabashima ,
Y. Tsunemi ,
A. Costanzo ,
E. Guttman-Yassky ,
J.M. Janes ,
A.M. DeLozier ,
M. Gamalo ,
T. Cardillo ,
F.P. Nunes ,
A.S. Paller ,
A. Wollenberg ,
K. Reich
December 2019
December 2019
Read this article at
ScienceOpenPublisher
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Author and article information
Comments
Comment on this article
scite_